Prestige Brands (NYSE: PBH) reported Q2 EPS of $0.65, $0.02 better than the analyst estimate of $0.63. Revenue for the quarter came in at $239.4 million versus the consensus estimate of $238.13 million.

• Revenue was $239.4 Million in Q2 Fiscal 2019; Organic Revenue Growth of 1.6% Excluding Household Cleaning Divestiture
• GAAP Diluted EPS Increased 4% to $0.59 in Q2; Adjusted EPS Increased 7% to $0.65
• Reduced Debt by $100 Million From Cash Generation and Divestiture Proceeds
• Reaffirming Previously Issued FY’19 Outlook

“We are pleased with second quarter results, driven by continued solid consumption trends across our diversified and leading consumer healthcare portfolio. We reduced our debt by $100 million during the quarter, continuing our prudent capital allocation strategy. Based on our results for the first six months of fiscal 2019 and expectations for the remainder of the year, we are well positioned to achieve our full-year fiscal 2019 guidance,” said Ron Lombardi, Chief Executive Officer of Prestige Consumer Healthcare.

GUIDANCE:

Prestige Brands sees FY2019 EPS of $2.84-$2.92, versus the consensus of $2.86. Prestige Brands sees FY2019 revenue of $985-995 million, versus the consensus of $990.43 million.

For earnings history and earnings-related data on Prestige Brands (PBH) click here.